A citation-based method for searching scientific literature

Mingzhao Xing, Ali S Alzahrani, Kathryn A Carson, Young Kee Shong, Tae Yong Kim, David Viola, Rossella Elisei, Bela Bendlová, Linwah Yip, Caterina Mian, Federica Vianello, R Michael Tuttle, Eyal Robenshtok, James A Fagin, Efisio Puxeddu, Laura Fugazzola, Agnieszka Czarniecka, Barbara Jarzab, Christine J O'Neill, Mark S Sywak, Alfred K Lam, Garcilaso Riesco-Eizaguirre, Pilar Santisteban, Hirotaka Nakayama, Roderick Clifton-Bligh, Giovanni Tallini, Elizabeth H Holt, Vlasta Sýkorová. J Clin Oncol 2015
Times Cited: 296







List of shared articles



Times cited


Molecular-Driven Therapy in Advanced Thyroid Cancer.
Kevin C Miller, Ashish V Chintakuntlawar. Curr Treat Options Oncol 2021
0

Molecular Pathology of Non-familial Follicular Epithelial-Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification.
Paula Soares, Antónia Afonso Póvoa, Miguel Melo, João Vinagre, Valdemar Máximo, Catarina Eloy, José Manuel Cameselle-Teijeiro, Manuel Sobrinho-Simões. Endocr Pathol 2021
5

Molecular Genetics of Follicular-Derived Thyroid Cancer.
Elisabetta Macerola, Anello Marcello Poma, Paola Vignali, Alessio Basolo, Clara Ugolini, Liborio Torregrossa, Ferruccio Santini, Fulvio Basolo. Cancers (Basel) 2021
2

Molecular testing for cytologically suspicious and malignant (Bethesda V and VI) thyroid nodules to optimize the extent of surgical intervention: a retrospective chart review.
Jessica Hier, Galit Avior, Marc Pusztaszeri, Joshua R Krasner, Noura Alyouha, Veronique-Isabelle Forest, Michael P Hier, Alex Mlynarek, Keith Richardson, Nader Sadeghi,[...]. J Otolaryngol Head Neck Surg 2021
0

Genetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid Carcinoma.
Antónia Afonso Póvoa, Elisabete Teixeira, Maria Rosa Bella-Cueto, Rui Batista, Ana Pestana, Miguel Melo, Thalita Alves, Mafalda Pinto, Manuel Sobrinho-Simões, Jorge Maciel,[...]. Cancers (Basel) 2021
1

How limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid-based cytology: Role of TERT promoter and BRAF V600E mutation analysis.
Marco Dell'Aquila, Vincenzo Fiorentino, Maurizio Martini, Sara Capodimonti, Tonia Cenci, Celestino Pio Lombardi, Marco Raffaelli, Alfredo Pontecorvi, Guido Fadda, Liron Pantanowitz,[...]. Cancer Cytopathol 2021
0

BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer.
Yubing Tao, Fei Wang, Xiaopei Shen, Guangwu Zhu, Rengyun Liu, David Viola, Rossella Elisei, Efisio Puxeddu, Laura Fugazzola, Carla Colombo,[...]. J Clin Endocrinol Metab 2021
0

Preoperative detection of the TERT promoter mutations in papillary thyroid carcinomas.
Tomoe Nakao, Michiko Matsuse, Vladimir Saenko, Tatiana Rogounovitch, Aya Tanaka, Keiji Suzuki, Miyoko Higuchi, Hisanori Sasai, Tsutomu Sano, Mitsuyoshi Hirokawa,[...]. Clin Endocrinol (Oxf) 2021
0

BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma.
Kyeong J Kim, Sin G Kim, Jie Tan, Xiaopei Shen, David Viola, Rossella Elisei, Efisio Puxeddu, Laura Fugazzola, Carla Colombo, Barbara Jarzab,[...]. Eur J Cancer 2020
11

Suspicious ultrasound and clinicopathological features of papillary thyroid carcinoma predict the status of TERT promoter.
Hui Shi, Le-Hang Guo, Yi-Feng Zhang, Hui-Jun Fu, Jia-Yi Zheng, Han-Xiang Wang, Chong-Ke Zhao, Hui-Xiong Xu. Endocrine 2020
2

Hypermethylation of the RSK4 promoter associated with BRAF V600E promotes papillary thyroid carcinoma.
Yanan Yin, Kui Che, Jianxia Hu, Hui Hua, Anbing Dong, Jueru Wang, Jiarui Yu, Qing Zhang, Shihua Zhao, Yuhang Zhao,[...]. Int J Oncol 2020
2


Molecular Profile of Locally Aggressive Well Differentiated Thyroid Cancers.
Leila J Mady, Michael C Grimes, Nayel I Khan, R Harsha Rao, Simion I Chiosea, Linwah Yip, Robert L Ferris, Yuri E Nikiforov, Sally E Carty, Umamaheswar Duvvuri. Sci Rep 2020
2

Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist?
Sylwia Szpak-Ulczok, Aleksandra Pfeifer, Dagmara Rusinek, Malgorzata Oczko-Wojciechowska, Malgorzata Kowalska, Tomasz Tyszkiewicz, Marta Cieslicka, Daria Handkiewicz-Junak, Krzysztof Fujarewicz, Dariusz Lange,[...]. Int J Mol Sci 2020
3

The Increased Risk of Thyroid Cancer-Specific Mortality With Tumor Size in Stage IVB Patients.
Junyi Zhang, Xiaoyun Cheng, Bin Su, Xingchun Wang, Lu Wang, Muthukumaran Jayachandran, Xiaoting Sun, Le Bu, Yueye Huang, Shen Qu. Front Oncol 2020
1

TERT-Regulation and Roles in Cancer Formation.
Marta Dratwa, Barbara Wysoczańska, Piotr Łacina, Tomasz Kubik, Katarzyna Bogunia-Kubik. Front Immunol 2020
8

Impact of Mutation Density and Heterogeneity on Papillary Thyroid Cancer Clinical Features and Remission Probability.
Carla Colombo, Marina Muzza, Maria Carla Proverbio, Delfina Tosi, Davide Soranna, Chiara Pesenti, Stefania Rossi, Valentina Cirello, Simone De Leo, Nicola Fusco,[...]. Thyroid 2019
14

Genetic-guided Risk Assessment and Management of Thyroid Cancer.
Mingzhao Xing. Endocrinol Metab Clin North Am 2019
18


The Combination of RET, BRAF and Demographic Data Identifies Subsets of Patients with Aggressive Papillary Thyroid Cancer.
Jose R W Martínez, Sergio Vargas-Salas, Soledad Urra Gamboa, Estefanía Muñoz, José Miguel Domínguez, Augusto León, Nicolás Droppelmann, Antonieta Solar, Mark Zafereo, F Christopher Holsinger,[...]. Horm Cancer 2019
4